Thye Dirk
Quince Therapeutics, Inc. · CEO and CMO
Thye Dirk is listed in public filings as director, officer: CEO and CMO. This Thye Dirk insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Quince Therapeutics, Inc. (QNCX). Investors use Thye Dirk's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $3.1M1M shares | Grant / ExerciseJan 23, 2026 | $3.1M1M shares | $3.08 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --255k shares | Grant / ExerciseDec 10, 2025 | Disclosure amount unavailable739.9k shares | -- | -- | |
| $181k150.9k shares | Grant / ExerciseJun 18, 2025 | $181.1K150.9k shares | $1.20 | -- | |
| $1.9M1.2M shares | Grant / ExerciseJan 28, 2025 | $1.9M1.2M shares | $1.60 | -- | |
| $591k843.9k shares | BuyAug 30, 2024 | $53.9K77k shares | $0.70 | -- | |
| $529k766.9k shares | BuyAug 29, 2024 | $53.5K77.5k shares | $0.69 | -- |